REVIEW article

Front. Immunol.

Sec. Nutritional Immunology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1575770

This article is part of the Research TopicNutrition, Inflammation and Immunity in Liver and Gastrointestinal DisordersView all 3 articles

Epithelial Barrier Hypothesis in the Context of Nutrition, Microbial Dysbiosis, and Immune Dysregulation in Metabolic Dysfunction-Associated Steatotic Liver

Provisionally accepted
  • 1Department of Medical Biology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Türkiye
  • 2Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Türkiye

The final, formatted version of the article will be published soon.

In recent years, the prevalence of chronic liver diseases, particularly Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), has increased significantly. This upward trend is largely associated with lifestyle-related factors such as unhealthy dietary habits, physical inactivity, and various environmental influences. Among the key elements contributing to the pathogenesis of MASLD, the integrity of the intestinal epithelial barrier emerges as a critical determinant, given its central role in maintaining immune homeostasis along the gut-liver axis. Disruption of this barrier, often driven by excessive consumption of saturated fats and refined carbohydrates in combination with low dietary fiber intake, can lead to microbial dysbiosis. This imbalance in the gut microbiota triggers immune dysregulation and promotes systemic inflammation, thereby exacerbating hepatic injury.This review discusses the contribution of epithelial barrier dysfunction to the development and progression of MASLD, with a particular focus on how increased intestinal permeability may initiate and sustain chronic liver inflammation. Additionally, the influence of dietary and environmental factors on epithelial integrity, immune responses, and the inflammatory cascade is addressed. A better understanding of the complex interplay between gut barrier impairment, immune modulation, and liver pathology may offer valuable insights into MASLD pathophysiology and contribute to the development of more targeted therapeutic strategies.

Keywords: Metabolic dysfunction-associated steatotic liver disease, epithelial barrier hypothesis, Gut-liver axis, nutrition, Gut Microbiota, Inflammation

Received: 12 Feb 2025; Accepted: 25 Apr 2025.

Copyright: © 2025 Çebi and Yilmaz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yusuf Yilmaz, Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Türkiye

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.